Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 09, 2025 10:25 ET | Source: Cytosurge AG

Cytosurge Announces Strategic Leadership Transition

Cytosurge appoints Simon Egli as CEO; co-founder Pascal Behr transitions to Board to ensure strategic guidance and growth.
October 15, 2024 09:00 ET | Source: Cytosurge AG; Lexogen GmbH

Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing

Cytosurge and Lexogen partner to advance Live-seq, integrating FluidFM® and LUTHOR HD to enable scalable, live-cell transcriptomics with high sensitivity.
May 29, 2024 08:30 ET | Source: Cytosurge AG

Cytosurge's CellEDIT Workflow, based on its Proprietary FluidFM® Technology, Receives Validation in Peer-Reviewed Publication

CellEDIT uses FluidFM for precise nuclear CRISPR/Cas9 injection, boosting efficiency by controlling RNP amounts, preserving traits in edited CHO-K1 cells.
May 29, 2024 02:30 ET | Source: Cytosurge AG

Cytosurge's CellEDIT Workflow, based on its Proprietary FluidFM® Technology, Receives Validation in Peer-Reviewed Publication

CellEDIT uses FluidFM for precise nuclear CRISPR/Cas9 injection, boosting efficiency by controlling RNP amounts, preserving traits in edited CHO-K1 cells.